The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-12
DOI
10.3389/fcell.2021.707677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
- (2021) Sitong Zhou et al. Cancer Cell International
- Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
- (2021) Jennifer A. Lo et al. Science Translational Medicine
- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Metabolic rewiring in melanoma drug-resistant cells
- (2020) Ivi Juliana Bristot et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line
- (2020) Yapeng Su et al. Nature Communications
- The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
- (2020) Christina Jessen et al. ONCOGENE
- Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
- (2020) Baohui Hu et al. Cancer Medicine
- MOVICS: an R package for multi-omics integration and visualization in cancer subtyping
- (2020) Xiaofan Lu et al. BIOINFORMATICS
- Epidemiology of Melanoma
- (2020) Nicole L. Bolick et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Melanosome maturation proteins Oca2, Mitfa and Vps11 are differentially required for cisplatin resistance in zebrafish melanocytes
- (2019) Kersten A. Peterson et al. EXPERIMENTAL DERMATOLOGY
- NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis
- (2019) Guangyan Zhou et al. NUCLEIC ACIDS RESEARCH
- Metabolic flexibility in melanoma: A potential therapeutic target
- (2019) Maria Rosaria Ruocco et al. SEMINARS IN CANCER BIOLOGY
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
- (2019) Michal Harel et al. CELL
- B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
- (2019) Daniel P. Hollern et al. CELL
- Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations
- (2019) Christian Menzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of mucosal melanoma
- (2019) Kelsey W. Nassar et al. SEMINARS IN CANCER BIOLOGY
- Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
- (2019) Nikita S. Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression
- (2018) Ke Li et al. ONCOGENE
- Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
- (2018) Muhammad Zubair Afzal et al. Journal for ImmunoTherapy of Cancer
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
- (2018) S. R. Rosario et al. Nature Communications
- Toil enables reproducible, open source, big biomedical data analyses
- (2017) John Vivian et al. NATURE BIOTECHNOLOGY
- A non-coding function of TYRP1 mRNA promotes melanoma growth
- (2017) David Gilot et al. NATURE CELL BIOLOGY
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Metabolic rewiring in melanoma
- (2016) B I Ratnikov et al. ONCOGENE
- Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
- (2016) Katherine Woods et al. Journal for ImmunoTherapy of Cancer
- GOplot: an R package for visually combining expression data with functional analysis: Fig. 1.
- (2015) Wencke Walter et al. BIOINFORMATICS
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- A flexible R package for nonnegative matrix factorization
- (2010) Renaud Gaujoux et al. BMC BIOINFORMATICS
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started